Aircraft industry

Lockheed Receives DOD Approval for F/A-22 Raptor and Raytheon Awarded Subcontract

Strategic Insights

Apr 19, 2005 — 1 min read

The Defense Department has given the green light to Lockheed Martin's F/A-22 Raptor to enter full-rate production. This decision marks a significant milestone for the aircraft program. Meanwhile, Raytheon Company has been awarded a $12.5 million subcontract from Northrop Grumman Corporation's ship systems sector for Life Cycle Engineering and Support for the LPD 17 class of amphibious warfare ships.

Key Takeaways:

Lockheed Martin's F/A-22 Raptor has been approved for full-rate production by the Department of Defense, marking a significant milestone for the aircraft program.
Raytheon Company has been awarded a $12.5 million subcontract from Northrop Grumman Corporation's ship systems sector for Life Cycle Engineering and Support for the LPD 17 class of amphibious warfare ships.
The Business of Stem Cell Research Conference, sponsored by U.S. BioDefense, Inc., will bring together C-Level executives from industry, politics, academia, and science to discuss the promise of stem cell research from a business perspective.
3M Inc. Chairman and CEO James McNerney Jr. expressed his confidence in the company's future, stating that he "strongly" believes in its future and has no plans to leave in any foreseeable time frame.

Statistics:

$12.5 million: The value of the subcontract awarded to Raytheon Company by Northrop Grumman Corporation's ship systems sector.
1: The number of foreseeable time frame in which James McNerney Jr. plans to leave 3M Inc.

Sources:

Lockheed Martin (NYSE: LMT)
Raytheon Company (NYSE: RTN)
Northrop Grumman Corporation
U.S. BioDefense, Inc. (OTCBB: UBDEE)
3M Inc. (NYSE:MMM)
Financial News USA (OTC: FNWU)

The End of American Hypergrowth

For two centuries, the US economy grew by adding workers. That's over.

Healthcare's $5.3 Trillion Drag

How Medical Spending Became America's Biggest Productivity Tax

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Researchers at the Wuhan University of Technology in China have made significant progress in the field of nanotechnology, specifically in the area of nanoindentation. A novel electromagnetic shock treatment (EST) method has been developed to enhance the microscale mechanical properties of a titanium alloy, with promising results obtained through array-based

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients

Research investigators at the Zhengzhou Central Hospital Affiliated to Zhengzhou University have made groundbreaking discoveries on the role of gut microbiota in determining the efficacy of immunotherapy for colon cancer patients. The study, which was recently published in Biochimica et Biophysica Acta, reveals that specific bacterial species and microbial metabolites

Read more

The End of American Hypergrowth

Healthcare's $5.3 Trillion Drag

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients